SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Sirna Therapeutics Inc
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
562 31 0 RNAI
Emcee:  advinfo Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
187 Companies have to be very careful about what they say when drugs/therapies are Baker-11/24/1998
186 Re: Press Release. Any idea why the company would be so cryptic about the resuThomas-11/24/1998
185 Press Release, FYI. Any idea why the company would be so cryptic about the resThomas-11/24/1998
184 Phase II trails on HIV starting at City of Hope: biz.yahoo.comBaker-11/24/1998
183 I'm not an expert at this but the main difference is XOMA's approach usBaker-11/17/1998
182 Someone more knowledgable tell me how this XOMA patent affects RZYM? Thanks. Xbob zagorin-11/17/1998
181 Thanks, bob. What is your take? I couldn't find any reports on lehman'Thomas-11/16/1998
180 pretty good analysis. here's one good research link. bio.com you might albob zagorin-11/14/1998
179 Thanks Baker, following is a post from the Yahoo RZYM board: Cheers, Thomas DiThomas-11/14/1998
178 You might want to check out the information on the company's home page wwwBaker-11/9/1998
177 HG and all, I read the recent releases with interest and enthusiasm. I am planThomas-11/9/1998
176 Baker, I sure would agree. They just keep the pipeline flowing. I picked up aHG-11/9/1998
175 Bob, another demonstration of the potential this stock has. Given what's iBaker-11/9/1998
174 Ribozyme Pharma Begins Phase I Trials Of Anti-Cancer Enzyme Dow Jones Newswiresbob zagorin-11/4/1998
173 Ribozyme Pharmaceuticals Initiates Angiozyme(TM) Trial in Healthy Volunteers -bob zagorin-11/4/1998
172 Bob, This is really getting interesting. 4 times the average volume two days iHG-11/2/1998
171 Bill, Sorry it took so long to answer. A friend of mine who is a bio-chemistrHG-10/30/1998
170 big move today. could it be angiozyme? bob zagorin-10/30/1998
169 DJ reports that RZYM should hear from FDA on its angiozyme application within abob zagorin-10/20/1998
168 HG: small caps getting some play. This is a very dangerous stock to hold if tbillkirn-10/19/1998
167 Interesting morning. Slow and steady rise. any thoughts? HG HG-10/19/1998
166 today's rise on the strongest volume in 4 mos. bob zagorin-9/28/1998
165 David, (traders) There are traders that will trade any price and volume, althouSnowShredder-9/25/1998
164 From what I know, day traders watch for any stock with unusually high volume/prBaker-9/24/1998
163 B; >>If these are day traders<<. I thought day traders practicedDavid Bogdanoff-9/23/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News